Sep 29, 2026 07:31AM
Sep 29, 2026 07:30AM
Aug 6, 2026 07:00AM
Jun 9, 2026 07:01AM
Jun 9, 2026 07:00AM
May 26, 2026 07:00AM
May 26, 2026 07:00AM Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027
Apr 30, 2026 07:00AM
Mar 9, 2026 07:00AM
Jan 9, 2026 08:05AM
Jan 9, 2026 08:04AM
Nov 19, 2025 06:40AM
Nov 13, 2025 04:06PM
Nov 13, 2025 04:05PM Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
Nov 6, 2025 07:00AM
Oct 30, 2025 07:01AM
Oct 30, 2025 07:00AM
Aug 7, 2025 07:00AM
May 30, 2025 07:01AM
May 30, 2025 07:00AM
May 13, 2025 07:00AM Cartesian Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
May 8, 2025 07:00AM
May 2, 2025 07:05AM
Apr 8, 2025 07:01AM
Apr 8, 2025 07:00AM
Apr 2, 2025 07:05AM
Apr 1, 2025 07:00AM
Mar 13, 2025 07:00AM Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Jan 28, 2025 06:39AM
Jan 27, 2025 07:00AM
Jan 13, 2025 07:00AM
Dec 3, 2024 06:01AM
Dec 3, 2024 06:00AM
Nov 21, 2024 07:00AM
Nov 7, 2024 07:00AM Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 5, 2024 09:00AM
Oct 15, 2024 07:03AM
Oct 15, 2024 07:00AM
Sep 13, 2024 06:44AM
Sep 9, 2024 07:03AM
Sep 9, 2024 07:00AM
Sep 3, 2024 07:05AM Cartesian Therapeutics (RNAC) Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
Sep 3, 2024 07:00AM
Aug 9, 2024 07:33AM
Aug 8, 2024 07:00AM
Jul 3, 2024 06:40AM
Jul 3, 2024 06:33AM
Jul 2, 2024 04:07PM
Jul 2, 2024 04:05PM Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
Jul 2, 2024 06:32AM

334,271 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All